Christopher Garabedian
2014
In 2014, Christopher Garabedian earned a total compensation of $5M as Former President and Chief Executive Officer at Sarepta Therapeutics, a 48% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $289,536 |
|---|---|
| Option Awards | $3,990,798 |
| Salary | $603,200 |
| Other | $119,492 |
| Total | $5,003,026 |
Garabedian received $4M in option awards, accounting for 80% of the total pay in 2014.
Garabedian also received $289.5K in non-equity incentive plan, $603.2K in salary and $119.5K in other compensation.
Rankings
In 2014, Christopher Garabedian's compensation ranked 1,552nd out of 13,032 executives tracked by ExecPay. In other words, Garabedian earned more than 88.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,552 out of 13,032 | 88th |
Division Manufacturing | 556 out of 4,966 | 89th |
Major group Chemicals And Allied Products | 176 out of 1,686 | 90th |
Industry group Drugs | 137 out of 1,365 | 90th |
Industry Pharmaceutical Preparations | 117 out of 1,043 | 89th |
Source: SEC filing on May 31, 2016.
Garabedian's colleagues
We found five more compensation records of executives who worked with Christopher Garabedian at Sarepta Therapeutics in 2014.
2014
Arthur Krieg
Sarepta Therapeutics
Chief Scientific Officer
2014
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2014
Edward Kaye
Sarepta Therapeutics
Chief Executive Officer
2014
David Howton
Sarepta Therapeutics
General Counsel
2014
Jayant Aphale
Sarepta Therapeutics